Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Shawver Laura Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 26,107 shares @ $7.0103, valued at $183k
Sold 18,897 shares @ $7.0631, valued at $133.5k
Exercised 26,017 options to buy @ $1.27, valued at $33k
Exercised 18,897 options to buy @ $1.27, valued at $24k
08/03/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 18,715 shares @ $7.1908, valued at $134.6k
Sold 36,281 shares @ $7.0909, valued at $257.3k
Exercised 18,715 options to buy @ $1.27, valued at $23.8k
Exercised 36,281 options to buy @ $1.27, valued at $46.1k
08/01/2023 144 Form 144 - Report of proposed sale of securities:
07/07/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 26,520 shares @ $6.725, valued at $178.3k
Sold 31,112 shares @ $6.414, valued at $199.6k
Sold 33,510 shares @ $6.343, valued at $212.6k
Exercised 26,520 options to buy @ $1.27, valued at $33.7k
Exercised 31,112 options to buy @ $1.27, valued at $39.5k
Exercised 33,510 options to buy @ $1.27, valued at $42.6k
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/28/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/02/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 73,059 shares @ $6.8, valued at $496.8k
Sold 26,941 shares @ $6.95, valued at $187.2k
Exercised 73,059 options to buy @ $1.27, valued at $92.8k
Exercised 26,941 options to buy @ $1.27, valued at $34.2k
06/01/2023 4 Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/26/2023 4 Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Gifted 12,099 shares @ $0
05/10/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 43,896 shares @ $4.58, valued at $201k
Sold 57,100 shares @ $6.16, valued at $351.7k
Sold 42,900 shares @ $5.31, valued at $227.8k
Exercised 57,100 options to buy @ $1.27, valued at $72.5k
Exercised 42,900 options to buy @ $1.27, valued at $54.5k
05/08/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2022 4 Shawver Laura (CEO) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Exercised 78,740 options to buy @ $1.27, valued at $100k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 41,597 options to buy @ $17.33, valued at $720.9k
05/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Shawver Laura (CEO) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Granted 27,500 shares @ $0
Granted 165,000 options to buy @ $4.85, valued at $800.3k
Granted 104,500 options to buy @ $4.85, valued at $506.8k
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2020 4 Shawver Laura (CEO) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Granted 562,631 options to buy @ $21, valued at $11.8M
12/03/2020 3 Shawver Laura (CEO) has filed a Form 3 on Silverback Therapeutics, Inc.
07/15/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/13/2020 4 Shawver Laura (Director) has filed a Form 4 on Nkarta, Inc.
Txns: Granted 10,700 options to buy @ $18, valued at $192.6k
Granted 18,300 options to buy @ $18, valued at $329.4k
07/09/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
01/24/2020 4 Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.
Txns: Gifted 80,706 shares @ $0
Unknown transaction of 220,595 shares @ $68, valued at $15M
Unknown transaction of 25,000 shares @ $68, valued at $1.7M
Disposed/sold 293,177 options to buy @ $0.93, valued at $272.7k
Disposed/sold 172,264 options to buy @ $0.63, valued at $108.5k
Disposed/sold 385,185 options to buy @ $11, valued at $4.2M
01/02/2020 4 Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.
Txns: Paid exercise price by delivering 210,010 shares @ $70.63, valued at $14.8M
Exercised 98,462 options to buy @ $0.93, valued at $91.6k
Exercised 12,912 options to buy @ $0.93, valued at $12k
Exercised 147,264 options to buy @ $0.63, valued at $92.8k
Exercised 120,815 options to buy @ $11, valued at $1.3M
12/19/2019 4 Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.
Txns: Granted 45,000 shares @ $0
01/25/2019 4 Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.
Txns: Exercised 25,000 shares @ $0.63, valued at $15.8k
Exercised 25,000 options to buy @ $0.63, valued at $15.8k
12/07/2018 4 Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.
Txns: Granted 506,000 options to buy @ $11, valued at $5.6M
12/06/2018 3 Shawver Laura (President and CEO) has filed a Form 3 on Synthorx, Inc.
02/04/2014 4 Shawver Laura (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC
Txns: Disposed/sold 20,000 options to buy @ $5.42, valued at $108.4k
Disposed/sold 15,000 options to buy @ $8.34, valued at $125.1k
05/23/2013 4 Shawver Laura (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC
Txns: Granted 15,000 options to buy @ $8.34, valued at $125.1k
06/08/2012 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy